Show simple item record

dc.contributorTansey EM
dc.contributorHumphrey P
dc.contributor.advisorTansey EM
dc.contributor.advisorZarros A
dc.contributor.otherGee D
dc.contributor.otherYabsley A
dc.contributor.otherWilkinson A
dc.date.accessioned2016-06-21T10:45:02Z
dc.date.available2016-06-21T10:45:02Z
dc.date.issued2016-06-21
dc.date.submitted2016-06-17T13:58:10.750Z
dc.identifier.urihttp://qmro.qmul.ac.uk/xmlui/handle/123456789/12989
dc.description.abstractInterview with Professor Patrick Humphrey, conducted by Professor Tilli Tansey, for the History of Modern Biomedicine Research Group, 08 February 2016, in the School of History, Queen Mary University of London. Transcribed by Mrs Debra Gee, and edited by Professor Tilli Tansey and Dr Apostolos Zarros. The project management and the technical support were undertaken by Mr Adam Wilkinson and Mr Alan Yabsley, respectively. Professor Patrick Humphrey OBE DSc PhD HonFBPhS (b. 1946) was born in South Africa and graduated from the School of Pharmacy, University of London, in 1968, with a strong interest in drug receptor theory. After obtaining a PhD in Pharmacology at St. Mary’s Hospital Medical School and briefly working as a Lecturer in the Department of Physiology there, he joined Allen & Hanburys at Ware to initiate a project on migraine. His work on cerebrovascular pharmacology led directly to the development of sumatriptan, the prototype of a new drug class (the triptans) for the treatment of migraine. During this time, he became the overall Director of the Glaxo Division of Pharmacology that was not only instrumental in the discovery of sumatriptan, but also naratriptan, alosetron, ondansetron, vapiprost, and salmeterol, covering a broad spectrum of therapeutic areas. He has received many important academic honours, including an honorary Professorship from the University of Cambridge, as well as the Royal Society’s Mullard medal. In 1999, he was awarded the OBE for ‘services to migraine research’. He maintains a passion for research aimed at drug discovery and was latterly the successful Head of Research and Executive Vice President at Theravance in South San Francisco from 2001 to 2008. He has over 300 published scientific papers and book chapters to his name and was ranked fourth in the list of total literature citations in Pharmacology and Toxicology from 1994 to 2004. He is currently consulting for a number of new, innovative pharmaceutical companies and is a non-executive Director on the Board of Verona Pharma plc.en_US
dc.description.sponsorshipThe History of Modern Biomedicine Research Group is funded by the Wellcome Trust, which is a registered charity (no. 210183). The current interview has been funded by the Wellcome Trust Strategic Award entitled “Makers of modern biomedicine: testimonies and legacy” (2012-2017; awarded to Professor Tilli Tansey).en_US
dc.language.isoenen_US
dc.relation.ispartofseriesHistory of Modern Biomedicine Interviews (Digital Collection);e2016020
dc.subjectHistory of Modern Biomedicine Research Groupen_US
dc.subjectAudio Interviewen_US
dc.subjectDrugs and Pharmacologistsen_US
dc.subjectNervous System and Neuroscientistsen_US
dc.titleHumphrey, Patrick: transcript of an audio interview (08-Feb-2016)en_US
dc.typeOtheren_US
dc.identifier.doi10.17636/01012989


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record